Previous 10 | Next 10 |
TransEnterix, Inc. (NYSEAmerican: TRXC) announced today that it plans to release third quarter financial and operating results after the market closes on Tuesday, November 12, 2019. The Company will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same da...
● Company’s action intended to increase the market price of its Common Stock in connection with its previously-announced pursuit of strategic alternatives ● Special Meeting of Stockholders to approve Reverse Stock Split scheduled for December 18, 2019 ● Prel...
Shares of ailing, robotic surgery device developer TransEnterix ( TRXC ) rallied in Thursday's after hours session after the company provided a business update containing several important disclosures: The previously announced sales agreement for the company's AutoLap system with Great...
TransEnterix (NYSEMKT: TRXC ) has engaged JPMorgan Securities, LLC to advise it on strategic alternatives while it implements a restructuring plan aimed at reducing operating expenses. More news on: TransEnterix, Inc., Healthcare stocks news, Stocks on the move, Read more ...
- Received initial $3 million payment in connection with amended AutoLap transaction - One Senhance System sold in the third quarter - The Company has engaged J.P. Morgan to assist its Board of Directors in evaluating strategic alternatives to enhance stockholder value - Anno...
Robotic-Assisted Surgery on the Rise In earlier articles, we have discussed how the medical robotics sector has strong growth prospects. Robotic surgery currently accounts for less than 10% of total surgeries, according to TransEnterix (NYSEMKT: TRXC ), with "continued expansion into addit...
We didn't surge into the close, and this was a good thing In yesterday's note, I introduced the possibility of a melt-up. Such an occurrence is hard to recognize when it is happening because a rally is a good thing. We all know however that too much of a good thing is a bad thing; good thi...
Going further above 3,000 today is close enough for "Government Work" Draghi restarting QE, cut rates 0.10%, and from what I understand, further cuts are possible. This was more of a muted response than what I expected, yet the futures are up higher on that news. The market momentum is cle...
TransEnterix (NYSEMKT: TRXC ) has drawn an Innovations of the Year award from the Society of Laparoendoscopic Surgeons for its Senhance Microlaparoscopy 3 mm instruments. More news on: TransEnterix, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Society of Laparoendoscopic Surgeons Recognizes Advanced Technology TransEnterix, Inc. (NYSE American: TRXC) a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced the company’s Senhance ...
News, Short Squeeze, Breakout and More Instantly...
Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter ...
Are These Penny Stocks Set To Bounce With The Market? As we move further into March, many penny stocks are continuing to climb. But it hasn’t come without some headwinds from the broader markets. While February didn’t close on a high note, March is getting off to an in...